ACHC Q1 Deep Dive: Operational Changes and Payer Headwinds Shape Outlook
Acadia Healthcare (ACHC) reported Q1 CY2026 revenue that exceeded analyst expectations, driven primarily by its acute inpatient psychiatric business. Despite the revenue beat, the company faced challenges in specialty facilities and elevated payer denials, leading to a negative market reaction. Management's outlook focuses on operational execution, mitigating payer risks, and leveraging new facilities to drive future growth and margin expansion.
Raymond James assumes Acadia Healthcare stock coverage with outperform rating
Raymond James has initiated coverage on Acadia Healthcare (NASDAQ:ACHC) with an Outperform rating and a $39.00 price target, citing strong demand for behavioral health services and effective management. The firm projects EBITDA growth of over 5% from 2025 through 2028, with the stock currently appearing undervalued.
Acadia Healthcare Company, Inc. (ACHC) stock price, news, quote and history
This article provides detailed financial information for Acadia Healthcare Company, Inc. (ACHC), including its current stock price, historical performance, key financial metrics, and analyst ratings. It highlights the company's business overview as a behavioral healthcare services provider and compares its stock performance against the S&P 500. The content includes earnings trends, valuation measures, and balance sheet data.
ACHC6023634 Bond Profile: Coupon and Redemption
This article provides a detailed profile of the ACHC6023634 bond issued by Acadia Healthcare Company, Inc. It outlines key facts about the bond, including its issuer type, issue and maturity dates, face value, and minimum denomination. The profile also covers the bond's classification, credit risk assessment, and details regarding its semi-annual fixed-rate coupon payments, including a schedule of upcoming payouts.
A court preliminarily approved a settlement involving Acadia Healthcare (ACHC). Final approval is pending.
A U.S. District Court has preliminarily approved a proposed settlement in shareholder derivative actions against Acadia Healthcare Company, Inc. (ACHC), involving a $12 million payment to Acadia from its insurers and the implementation of significant corporate governance reforms. Final court approval is still pending for both the settlement and a requested $4.75 million in attorneys' fees and expenses. This settlement aims to resolve claims alleging fiduciary duty breaches, corporate asset waste, and unjust enrichment by certain individual defendants.
ACADIA HEALTHCARE COMPANY, INC. : LEERINK PARTNERS RAISES TARGET PRICE TO $33 FROM $30
Leerink Partners has increased its target price for Acadia Healthcare Company, Inc. from $30 to $33. This update reflects an analyst's revised valuation for the healthcare company's stock.
Cash Flow Improvement Could Be A Game Changer For Acadia Healthcare (ACHC)
Acadia Healthcare Company (ACHC) is showing stronger cash generation due to maturing psychiatric and specialty treatment facilities, disciplined capital spending, and new joint-venture hospitals. This improved cash flow is expected to support debt reduction and lead to positive free cash flow in the second half of 2026. The shift from headline capacity growth to actual cash generation provides a clearer investment narrative, though risks like Medicaid reimbursement pressures and underperforming facilities remain.
Form DEF 14A Acadia Healthcare Company Inc For: 23 September By Investing.com
This article reports on the filing of Form DEF 14A by Acadia Healthcare Company Inc. The filing was made for September 23. The article provides financial markets data including stock performances, commodity prices, and bond yields.
Leerink Partners maintains Market Perform rating on Acadia Healthcare Co, $33 price target
Leerink Partners has reiterated its "Market Perform" rating for Acadia Healthcare Co (ACHC), setting a price target of $33.00, which suggests a 12.4% upside from its previous close. The analyst note highlighted operational concerns, indicating a deterioration in business operations, and significant legal liabilities complicating the company's valuation. These factors make the stock less appealing despite potential upsides from operational stabilization or strategic buyer interest.
A Look at Acadia Healthcare Co Inc (ACHC) After 3.5% Gain -- GF Value $41.65 vs Price $29.37
Acadia Healthcare Co Inc (ACHC) saw a 3.5% gain, closing at $29.37, which is significantly below its GF Value™ estimate of $41.65, suggesting it is undervalued. Despite this, the company is currently unprofitable and cash-flow-negative, making a Price-to-Sales (P/S) approach more appropriate for valuation than earnings-based metrics. The GF Score™ of 69/100 indicates above-average performance, though financial strength and valuation remain weak points.
Acadia Healthcare stock gains as index weight and growth outlook support momentum
Acadia Healthcare (ACHC) stock is performing well, supported by its inclusion in the S&P Composite 1500 Pure Value Index. Analysts project a 14.4% increase in earnings by 2027 and steady revenue growth, driven by strong demand for mental health and substance use treatment. The company's consistent outperformance of earnings estimates also contributes to investor confidence.
Zacks Industry Outlook Tenet, Acadia and Community Health Systems
The Zacks Medical-Hospital industry is experiencing favorable demand due to an aging population and increased utilization, but faces margin pressures from rising costs and less favorable payer mixes. The industry's positive outlook is supported by a strong Zacks Industry Rank and analysts' optimistic earnings estimates for 2026. Tenet Healthcare, Acadia Healthcare, and Community Health Systems are highlighted as key players adapting through strategic initiatives and cost discipline.
Acadia Healthcare Company (ACHC) Heads To Jefferies Conference, Is A 15% Undervaluation Still Intact?
Acadia Healthcare Company (ACHC) is attracting investor attention ahead of its presentation at the Jefferies Healthcare Services and Technology Conference. Despite recent share price cooling, ACHC has seen significant year-to-date gains. Simply Wall St's analysis suggests the company is currently 15% undervalued, with a fair value of $32.21 against a last close of $27.38, emphasizing its growth and turnaround plans.
Acadia Healthcare Company, Inc. - Common Stock (Nasdaq:ACHC) Detailed Stock Data
This article provides detailed stock data for Acadia Healthcare Company, Inc. (Nasdaq: ACHC), including current trading information, historical prices, and performance metrics. It lists the stock's price, daily high/lows, 52-week range, volume, and percentage changes over various periods.
Acadia Healthcare Company, Inc. (ACHC) stock price, news, quote and history
This page provides comprehensive financial information for Acadia Healthcare Company, Inc. (ACHC), including its current stock price, historical data, and analyst ratings. It details the company's overview, recent performance against the S&P 500, earnings trends, and key financial statistics. The article also includes a comparison tool to analyze ACHC alongside similar companies in the medical care facilities industry.
Can Acadia's Turnaround Strategy Drive Long-Term Shareholder Value?
Acadia Healthcare Company, Inc. (ACHC) is implementing a turnaround strategy focused on maximizing returns from its existing facilities rather than pursuing aggressive growth. Following a period of challenges, Acadia has resolved billing disputes, strengthened compliance, and seen revenue growth in Q1 2026, leading to increased full-year adjusted EBITDA guidance. The company, which is the largest standalone behavioral health provider in the U.S., aims to convert past investments into improved profitability amid rising demand for mental health services.
San Diego Treatment Center Hit With $105 Million Verdict After Counselor Reported Sexual Harassment
A San Diego jury awarded $105 million to a former substance abuse counselor who alleged she was fired after reporting sexual harassment, a hidden camera, and patient safety concerns at a treatment facility. The verdict includes $35 million in compensatory damages and $70 million in punitive damages against San Diego Health Alliance, an indirect subsidiary of Acadia Healthcare. The company denies retaliation and plans to challenge the verdict through post-trial motions and appeals, noting that the punitive damages are substantial despite a 2-to-1 ratio with compensatory damages, which may be subject to constitutional review.
Avoiding Lag: Real-Time Signals in (ACHC) Movement
This article analyzes Acadia Healthcare Company Inc. (ACHC) using AI models to provide real-time trading signals and strategies. It identifies a positive near-term sentiment but a weak mid-term bias within a strong long-term context, highlighting a significant risk-reward setup. The analysis offers specific entry, target, and stop-loss points for position, momentum breakout, and risk hedging strategies across different timeframes.
Influential Women Profiles Allyson Baez: Treatment Placement Specialist at Acadia Healthcare
This article profiles Allyson Baez, a Treatment Placement Specialist at Acadia Healthcare, highlighting her decade-plus experience in psychiatric and behavioral healthcare. Baez connects individuals with appropriate treatment for mental health, substance use, and trauma, driven by a passion for helping others and reducing stigma. She emphasizes the importance of compassion, balance, and continued learning in the field, especially for young women entering the profession.
Acadia Healthcare Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Acadia Healthcare Company, Inc. - ACHC
Kahn Swick & Foti, LLC (KSF) is continuing its investigation into Acadia Healthcare Company, Inc. (ACHC) regarding potential breaches of fiduciary duties by its officers and directors and violations of state or federal laws. This investigation follows a voluntary request for information from the U.S. Attorney's Office and a grand jury subpoena related to Acadia's admissions, length of stay, and billing practices, as well as a lowered full-year 2024 revenue outlook. A securities class action lawsuit against Acadia is also moving forward after the company's motion to dismiss was denied.
Deutsche Bank AG Invests $49.75 Million in Acadia Healthcare Company, Inc. $ACHC
Deutsche Bank AG has acquired a new stake of 1,684,607 shares in Acadia Healthcare Company, Inc. (NASDAQ:ACHC), valued at approximately $49.75 million, representing 1.81% of the company. Other institutional investors have also adjusted their positions in Acadia Healthcare. The company recently reported earnings of $0.38 per share, beating consensus estimates, and analysts have set new price targets for ACHC shares, with a consensus "Hold" rating.
Acadia Healthcare Data Scientist Salaries in Bowling Green, KY
The average Data Scientist at Acadia Healthcare in Bowling Green, KY earns an estimated $138,908 annually, comprising a $117,570 base salary and a $21,337 bonus. This compensation is higher than the US average for Data Scientists, with salaries ranging from $47,500 to $280,000. Data Scientists at Acadia Healthcare generally believe they are not compensated fairly and are dissatisfied with their benefits.
152,445 Shares in Acadia Healthcare Company, Inc. $ACHC Bought by Lisanti Capital Growth LLC
Lisanti Capital Growth LLC has acquired 152,445 shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) worth approximately $4.5 million, representing about 0.16% of the company. Despite Acadia Healthcare reporting better-than-expected quarterly EPS and revenue, its revenue declined year-over-year, and it posted a negative net margin. Analyst sentiment is mixed, with an overall "Hold" rating and an average price target of $29.85, although some firms have raised their price objectives.
Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Receives Average Recommendation of "Hold" from Analysts
Acadia Healthcare Company, Inc. (NASDAQ:ACHC) has received a "Hold" consensus rating from analysts, with an average 12-month price target of $29.85. The company recently reported quarterly EPS of $0.38, exceeding estimates, and revenues of $865.84 million, despite a slight year-over-year decline. Major institutional investors, including BlackRock and Goldman Sachs, have either established or expanded their positions in Acadia Healthcare.
U.S. Mental Health Treatment Market Report 2026–2030: Evaluating $159 Billion Forecast, Digital App Adoption, and Strategies of Acadia Healthcare, UHS, Talkspace, and Elevance Health
A new report by Marketdata LLC examines the U.S. mental health services market, forecasting its value to reach $159 billion by 2030. The study analyzes the impact of clinical facility expansion, payer integration, and the growth of digital therapy platforms from companies like Acadia Healthcare, UHS, Talkspace, and Elevance Health. It also addresses the industry's fragmentation, sustained demand, technology adoption, and ongoing challenges related to workforce shortages and accessibility.
Does Raised 2026 EBITDA Guidance And Expansion Strategy Change The Bull Case For Acadia Healthcare (ACHC)?
Acadia Healthcare (ACHC) recently increased its 2026 adjusted EBITDA guidance and is pursuing network expansion through joint ventures and new facilities, driven by demand for behavioral health services. While this indicates management confidence in earnings potential, the company still faces pressure from operating and legal costs. The article explores how this upgraded guidance impacts Acadia's investment outlook, emphasizing that unresolved legal and regulatory investigations remain a significant risk for investors despite the positive short-term outlook.
Does Raised 2026 EBITDA Guidance And Expansion Strategy Change The Bull Case For Acadia Healthcare (ACHC)?
Acadia Healthcare (ACHC) recently increased its 2026 adjusted EBITDA guidance and is expanding its network through joint ventures and new facilities, driven by demand for behavioral health services. While this indicates management confidence in growth, the company continues to face margin pressure and legal costs. Investors need to weigh the potential for sustained demand and expansion against ongoing operational and legal expenses to determine long-term profitability.
Does Raised 2026 EBITDA Guidance And Expansion Strategy Change The Bull Case For Acadia Healthcare (ACHC)?
Acadia Healthcare has increased its 2026 adjusted EBITDA guidance and is pursuing network expansion despite facing operating and legal costs. While this indicates management's growing confidence in its expansion strategy, concerns persist regarding eroding earnings quality due to unresolved legal and regulatory investigations. The article suggests that while the guidance uplift is positive, the impact on durable profitability and the risks associated with legal costs remain central to the investment narrative.
Should You Continue to Hold ACHC Stock at an 18.17X P/E Valuation?
Acadia Healthcare Company, Inc. (ACHC) benefits from strong demand for behavioral health services and is expanding its network. While the company shows solid growth and financial health, its stock trades at a premium compared to industry peers. ACHC carries a Zacks Rank #3 (Hold) due to its valuation and increasing operating expenses despite positive earnings surprises and raised EBITDA guidance.
UBS Adjusts Price Target on Acadia Healthcare to $1.50 From $4.50, Keeps Neutral Rating
UBS has adjusted its price target for Acadia Healthcare (referred to as Accendra Health in the article) to $1.50, down from $4.50, while maintaining a Neutral rating on the stock. This adjustment follows similar downgrades and price target reductions from other firms like Citigroup and Baird, indicating a broader shift in analyst sentiment. The company, which provides products and services for health beyond the hospital, recently updated its earnings guidance and reported Q2 2026 results.
Wellington Group (ACHC) discloses 6.15% beneficial stake in Acadia Healthcare
Wellington Management Group LLP and its related entities have disclosed a 6.15% beneficial ownership stake in Acadia Healthcare Company, Inc. (ACHC) through a Schedule 13G/A SEC filing. The ownership is held by investment advisory clients of various Wellington investment advisers, indicating shared voting and dispositive powers rather than sole control by Wellington. The filing details the specific shared voting and dispositive powers held by different Wellington entities over Acadia Healthcare shares.
Did Acadia Healthcare Company, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Halper Sadeh LLC is investigating whether certain officers and directors of Acadia Healthcare Company, Inc. (ACHC) breached their fiduciary duties to shareholders. The law firm is encouraging long-term shareholders to contact them to discuss legal rights and options, including seeking corporate governance reforms, return of funds, or other relief. Shareholder participation is highlighted as a way to improve company policies and enhance shareholder value.
Did Acadia Healthcare Company, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Halper Sadeh LLC, an investor rights law firm, is investigating whether officers and directors of Acadia Healthcare Company, Inc. (NASDAQ: ACHC) breached their fiduciary duties to shareholders. The firm encourages long-term shareholders of Acadia stock to contact them to discuss potential legal rights and options, including seeking corporate governance reforms or financial incentives. Halper Sadeh LLC emphasizes that shareholder involvement can enhance transparency, accountability, and management, ultimately increasing shareholder value.
Royal Bank of Canada Purchases 274,785 Shares of Acadia Healthcare Company, Inc. $ACHC
Royal Bank of Canada significantly increased its stake in Acadia Healthcare Company, Inc. (ACHC) by 7,896.1% in the first quarter, acquiring an additional 274,785 shares. The fund now holds 278,265 shares valued at approximately $6.5 million. This increase makes Royal Bank of Canada a significant institutional investor in Acadia, which recently reported earnings exceeding analyst expectations despite a slight revenue decline.
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Acadia Healthcare
Faruqi & Faruqi, LLP is investigating potential securities claims against Acadia Healthcare Company, Inc. on behalf of investors who suffered losses exceeding $100,000 between February 28, 2020, and September 26, 2024. The investigation stems from allegations that Acadia Healthcare made false and misleading statements regarding its business practices, including holding patients against their will and deceiving insurance providers. Investors are encouraged to contact the firm by the December 16, 2024, lead plaintiff deadline.
Acadia Healthcare Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Acadia Healthcare Company, Inc. - ACHC
Kahn Swick & Foti, LLC (KSF) is continuing its investigation into Acadia Healthcare Company, Inc. (ACHC) regarding potential breaches of fiduciary duties by its officers and directors and violations of state or federal laws. This investigation follows disclosures by Acadia Healthcare concerning a federal inquiry into its practices and a lowered revenue outlook, leading to a securities class action lawsuit against the company. KSF is urging long-term shareholders or individuals with relevant information to contact the firm.
Acadia Healthcare (ACHC) Is Up 6.4% After Raising 2026 Revenue Outlook Despite Softer Q2 Earnings
Acadia Healthcare (ACHC) reported softer Q2 2026 earnings but saw its stock rise 6.4% after raising its full-year 2026 revenue guidance to US$3.40–US$3.45 billion. This indicates management's confidence in underlying demand, despite a decline in net income and EPS year-over-year. The article suggests that future growth hinges on increased volumes and pricing offsetting cost pressures, while also noting ongoing legal and regulatory risks.
Acadia Healthcare (ACHC) Is Up 6.4% After Raising 2026 Revenue Outlook Despite Softer Q2 Earnings
Acadia Healthcare (ACHC) reported softer Q2 2026 earnings but saw its stock rise 6.4% after management raised its full-year 2026 revenue guidance to US$3.40–US$3.45 billion. This optimism reflects confidence in demand and growth despite execution risks and cost pressures. The company's future hinges on whether higher volumes and pricing can overcome operational drags and weaker near-term profitability.
El Pasoan wins top award from Acadia Healthcare
Donna Juarez, an El Paso healthcare professional, has been awarded the prestigious Values in Action Peak Award by Acadia Healthcare. Juarez, who serves as the director of military veteran affairs for Rio Vista Behavioral Health, was selected from 500 nominees out of 29,000 employees. This award recognizes employees who demonstrate excellence, compassion, and service within the company.
A Look at Acadia Healthcare Co Inc (ACHC) After 4.7% Decline -- GF Value $41.52 vs Price $30.73
Acadia Healthcare Co Inc (ACHC) experienced a 4.7% decline, closing at $30.73, and is considered 26.0% undervalued according to GuruFocus' GF Value of $41.52. Despite an "Above Average" GF Score of 69/100, the company faces challenges with unprofitability and negative cash flow, warranting caution from investors. While gurus show positive sentiment by increasing stakes, the absence of insider transactions in recent months indicates potential near-term uncertainty.
Edgestream Partners L.P. Sells 42,454 Shares of Acadia Healthcare Company, Inc. $ACHC
Edgestream Partners L.P. significantly reduced its stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by selling 42,454 shares in the first quarter, retaining 20,119 shares valued at $471,000. Despite this, Acadia Healthcare's stock opened up 1.8% at $32.24 and reported strong quarterly earnings of $0.38 EPS, exceeding estimates, though revenue was slightly down year-over-year. Analyst sentiment is mixed, with several firms raising price targets and maintaining Buy/Outperform ratings, yet the overall MarketBeat consensus is a "Hold" with a target price of $29.85.
FMR LLC discloses 5.5% Acadia Healthcare (ACHC) stake in amended ownership filing
FMR LLC has filed an amended Schedule 13G, disclosing a beneficial ownership of 5.5% in Acadia Healthcare Company, Inc. (ACHC), effective as of June 30, 2026. This translates to 5,015,726.57 shares, with FMR LLC exercising sole voting power over 5,011,333 shares and sole dispositive power over all beneficially owned shares. Abigail P. Johnson is also listed as a reporting person with sole dispositive power over the same number of shares.
Exclusive: Bradford Health Services Adds 2 Execs with UHS, Acadia Backgrounds
Bradford Health Services has appointed two new executives, Justin Adams as COO and John Hollinsworth to its Board of Directors, bringing 48 years of combined behavioral health experience from companies like UHS and Acadia. These appointments signify a shift in Bradford's growth strategy towards standardized practices, improved outcomes, and disciplined expansion rather than just acquisition-led growth. The company aims to refine programs using client data, leverage technology for care delivery, and meet evolving patient needs.
Acadia Healthcare Company Stock Short Interest Falls to 37.33%
This article reports on the significant decrease in short interest for Acadia Healthcare Company (ACHC) stock, which fell by 37.33% in the second half of July. Despite this reduction, a substantial percentage of the company's shares are still held short, indicating continued investor sentiment regarding its future performance. The article also provides details on the company's financial metrics and analyst ratings.
121,500 Shares in Acadia Healthcare Company, Inc. $ACHC Acquired by Militia Capital Management LLC
Militia Capital Management LLC acquired 121,500 shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) valued at approximately $2.84 million in the first quarter, representing about 0.13% of the company. Other institutional investors also adjusted their holdings in ACHC, which reported quarterly EPS of $0.38 against an $0.35 consensus, and revenue of $865.84 million, beating expectations despite a slight year-over-year decline. Analyst sentiment for Acadia Healthcare is mixed, with an overall "Hold" rating and an average price target of $29.85.
Sei Investments Co. Raises Stake in Acadia Healthcare Company, Inc. $ACHC
Sei Investments Co. increased its stake in Acadia Healthcare Company, Inc. by 39% in the first quarter, now holding 316,398 shares valued at $7.4 million. Despite mixed analyst ratings, the company beat its quarterly earnings and revenue expectations, reporting $0.38 EPS and $865.84 million in revenue. Other institutional investors also adjusted their holdings in Acadia Healthcare.
ETFs Investing in Acadia Healthcare Company, Inc. Stocks
This article lists various Exchange Traded Funds (ETFs) that hold stocks of Acadia Healthcare Company, Inc. It provides a detailed table including each ETF's market value, weight of Acadia Healthcare stock, issuer, management style, focus, expense ratio, AUM, price, change percentage, relative volume, and 3-year NAV total return. The information aims to help investors understand how to invest in stocks like Acadia Healthcare through diversified ETFs, offering more opportunities with lower risk.
Why Acadia Healthcare (ACHC) Is Down 17.3% After Raising 2026 Revenue Guidance Amid Earnings Drop
Acadia Healthcare (ACHC) shares dropped 17.3% despite the company raising its 2026 revenue guidance to US$3.40–US$3.45 billion. This follows a second quarter where sales were flat and net income sharply declined to US$10.93 million. The market reaction indicates that ongoing legal and regulatory risks and weak quarterly earnings overshadowed the positive long-term outlook driven by new facility ramp-ups.
Why Acadia Healthcare (ACHC) Is Down 17.3% After Raising 2026 Revenue Guidance Amid Earnings Drop
Acadia Healthcare (ACHC) saw its stock drop despite raising its 2026 revenue guidance, attributed to flat quarterly revenue and a sharp decline in net income. The company's increased full-year outlook relies on new facilities ramping up, while ongoing legal and regulatory issues continue to pressure profitability. Investors are advised to consider these risks alongside the projected long-term demand for behavioral health services and the company's expanding bed base.
Acadia Healthcare Number of Employees 2026 | Employee Count & Headcount Data
Acadia Healthcare (ACHC) had approximately 24,945 employees worldwide as of March 2026, a 1.5% decline from 2023. The company is actively hiring, with 2,511 active job postings in 2026, and its workforce is primarily concentrated in the United States. Employee sentiment is reported as negative and declining, while the average salary is $70,758.
